The store will not work correctly when cookies are disabled.
5-Biphenyl-4-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA420943
PubChem CID: 10314059
Max Phase: Preclinical
Molecular Formula: C23H18N2
Molecular Weight: 322.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C1=C(c2ccc(-c3ccccc3)cc2)N2CCN=C2c2ccccc21
Standard InChI: InChI=1S/C23H18N2/c1-2-6-17(7-3-1)18-10-12-19(13-11-18)22-16-20-8-4-5-9-21(20)23-24-14-15-25(22)23/h1-13,16H,14-15H2
Standard InChI Key: ODUACGSWQIDXJW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 29 0 0 0 0 0 0 0 0999 V2000
3.4292 -5.2667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9125 -5.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4625 -4.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9500 -4.3625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4000 -5.2542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9125 -6.1750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4167 -4.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0625 -4.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2542 -4.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3542 -5.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3542 -4.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9500 -4.1667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9542 -5.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8542 -4.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9500 -5.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9500 -6.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8667 -5.5375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9042 -4.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1542 -5.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1500 -4.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3542 -5.2250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3667 -4.6167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7500 -4.1625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7500 -5.2000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0542 -4.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 12 1 0
10 8 2 0
11 8 1 0
12 11 2 0
13 10 1 0
14 9 1 0
15 1 1 0
16 15 1 0
17 5 1 0
18 7 1 0
19 14 1 0
20 14 2 0
21 17 2 0
22 18 2 0
23 20 1 0
24 19 2 0
25 23 2 0
6 16 1 0
5 7 2 0
13 9 2 0
22 21 1 0
24 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 322.41 | Molecular Weight (Monoisotopic): 322.1470 | AlogP: 4.93 | #Rotatable Bonds: 2 |
Polar Surface Area: 15.60 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.13 | CX LogP: 4.71 | CX LogD: 4.52 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.65 | Np Likeness Score: -0.20 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |